Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.
Lorizzo K, Fazio N, Radice D, Boselli S, Ariu L, Zampino MG, Nolè F, Magni E, Ardito R, Minchella I, Rocca A, Di Meglio G, Squadroni M, de Braud F. Lorizzo K, et al. Among authors: di meglio g. Cancer Chemother Pharmacol. 2009 Jul;64(2):301-6. doi: 10.1007/s00280-008-0871-y. Epub 2008 Nov 26. Cancer Chemother Pharmacol. 2009. PMID: 19034450
Miliary hepatic metastases from neuroendocrine carcinoma.
Fazio N, Di Meglio G, Lorizzo K, de Brand F. Fazio N, et al. Among authors: di meglio g. Dig Surg. 2008;25(5):330. doi: 10.1159/000158907. Epub 2008 Oct 1. Dig Surg. 2008. PMID: 18827485 No abstract available.
Right pelvic mass in a patient with a radically resected carcinoid of the appendix.
Fazio N, Luca F, Monfardini L, Pelosi G, Bodei L, Lorizzo K, Di Meglio G, Gibelli B, Ravizza D, Bonomo G, Grana CM, Baio S, Squadroni M, Paganelli G, de Braud F. Fazio N, et al. Among authors: di meglio g. Gut. 2009 Sep;58(9):1200, 1259. doi: 10.1136/gut.2008.167452. Gut. 2009. PMID: 19671553 No abstract available.
Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors.
Panzuto F, Campana D, Fazio N, Brizzi MP, Boninsegna L, Nori F, Di Meglio G, Capurso G, Scarpa A, Dogliotti L, De Braud F, Tomassetti P, Delle Fave G, Falconi M. Panzuto F, et al. Among authors: di meglio g. Neuroendocrinology. 2012;96(1):32-40. doi: 10.1159/000334038. Epub 2011 Dec 28. Neuroendocrinology. 2012. PMID: 22205326
Metachronous Colon Metastases from Gastric Adenocarcinoma: A Case Report.
Pace U, Contino G, Chiappa A, Bertani E, Bianchi PP, Fazio N, Renne G, Di Meglio G, Andreoni B. Pace U, et al. Among authors: di meglio g. Case Rep Oncol. 2009 May 26;2(2):92-96. doi: 10.1159/000215945. Case Rep Oncol. 2009. PMID: 20740169 Free PMC article.
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review.
Pellegrino B, Sikokis A, Bersanelli M, Leonetti A, Leonardi F, Di Meglio G, Buti S. Pellegrino B, et al. Among authors: di meglio g. Gynecol Obstet Invest. 2016;81(5):385-93. doi: 10.1159/000446954. Epub 2016 Jun 17. Gynecol Obstet Invest. 2016. PMID: 27309542 Review.
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol.
Bongiovanni A, Liverani C, Pusceddu S, Leo S, Di Meglio G, Tamberi S, Santini D, Gelsomino F, Pucci F, Berardi R, Lolli I, Bergamo F, Ricci S, Foca F, Severi S, Ibrahim T; SENECA Study Team Investigators. Bongiovanni A, et al. Among authors: di meglio g. BMJ Open. 2020 Jul 19;10(7):e034393. doi: 10.1136/bmjopen-2019-034393. BMJ Open. 2020. PMID: 32690499 Free PMC article.
50 results